tirzepatide φαρμακο FDA Grants a New Indication for Obesity Management Mounjaro (Tirzepatide): Δόση, Αποτελέσματα, Παρενέργειες

The goal isnt to eat less at all costs

References Amin NH, Kumar NS, Schickendantz MS

Microscopic liposomes are rapidly absorbed through the oral mucosa and lymphatic system, enabling direct intracellular delivery at levels that can surpass traditional intravenous therapies

In 12 months old mice, dAla(2)GIP was given once daily for 21 days

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and for weight management in adults with obesity or overweight with weight-related comorbidities